We proposed a model in which up-regulation of miR-429 in Ginsenoside Rg3-AGSR-CDDP cells may alleviate cisplatin resistance of GC cells via modulating SOX2 and the PI3K/Akt/mTOR signaling axis (Figure 7). This evidence concerns the gene SOX2 and gastric cancer.